J Korean Neurosurg Soc.  2022 May;65(3):415-421. 10.3340/jkns.2020.0224.

Long-Term Management of Seizures after Surgical Treatment of Supratentorial Cavernous Malformations : A Retrospective Single Centre Study

• Dziedzic TA
• Koczyk K
• Nowak A
• Maj E
• Marchel A

• KMID: 2529586
• DOI: http://doi.org/10.3340/jkns.2020.0224

Abstract

Objective
: Seizure recurrence after the first-ever seizure in patients with a supratentorial cerebral cavernous malformation (CCM) is almost certain, so the diagnosis and treatment of epilepsy is justified. The optimal method of management of these patients is still a matter of debate. The aim of our study was to identify factors associated with postoperative seizure control and assess the surgical morbidity rate.
Methods
: We retrospectively analysed 45 consecutive patients with a supratentorial CCM and symptomatic epilepsy in a single centre. Pre- and postoperative epidemiological data, seizure-related patient histories, neuroimaging results, surgery details and outcomes were obtained from hospital medical records. Seizure outcomes were assessed at least 12 months after surgery.
Results
: Thirty-five patients (77.8%) were seizure free at the long-term follow-up (Engel class I); six (13,3%) had rare, nocturnal seizures (Engel class II); and four (8.9%) showed meaningful improvement (Engel class III). In 15 patients (33%) in the Engel I group; it was possible to discontinue antiepileptic medication. Although there was not statistical significance, our results suggest that patients can benefit from early surgery. No deaths occurred in our study, and mild postoperative neurologic deficits were observed in two patients (4%) at the long-term follow-up.
Conclusion
: Surgical resection of CCMs should be considered in all patients with a supratentorial malformation and epilepsy due to the favourable surgical results in terms of the epileptic seizure control rate and low postoperative morbidity risk, despite the use of different predictors for the seizure outcome.

Keyword

Hemangioma, cavernous, central nervous system; Drug reistant epilepsy; Epilepsy surgery; Epilepsy outcome

Reference

References

1. Akers A, Al-Shahi Salman R, Awad IA, Dahlem K, Flemming K, Hart B, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board clinical experts panel. Neurosurgery. 80:665–680. 2017.

2. Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia. 48:559–563. 2007.

3. Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E. Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg. 99:179–183. 1997.

4. Casazza M, Broggi G, Franzini A, Avanzini G, Spreafico R, Bracchi M, et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery. 39:26–32. discussion 32-34. 1996.

5. Chang EF, Gabriel RA, Potts MB, Garcia PA, Barbaro NM, Lawton MT. Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery. 65:31–37. discussion 37-38. 2009.

6. Cohen DS, Zubay GP, Goodman RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg. 83:237–242. 1995.

7. Dammann P, Wrede K, Jabbarli R, Neuschulte S, Menzler K, Zhu Y, et al. Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation. J Neurosurg. 126:1303–1311. 2017.

8. Dziedzic T, Kunert P, Matyja E, Ziora-Jakutowicz K, Sidoti A, Marchel A. Familial cerebral cavernous malformation. Folia Neuropathol. 50:152–158. 2012.

9. Englot DJ, Han SJ, Lawton MT, Chang EF. Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg. 115:1169–1174. 2011.

10. Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci. 26:390–394. 2006.

11. Hammen T, Romstöck J, Dörfler A, Kerling F, Buchfelder M, Stefan H. Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure. 16:248–253. 2007.

12. Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R, et al. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 76:1548–1554. 2011.

13. Kim W, Stramotas S, Choy W, Dye J, Nagasawa D, Yang I. Prognostic factors for post-operative seizure outcomes after cavernous malformation treatment. J Clin Neurosci. 18:877–880. 2011.

14. Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J. Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien). 153:261–270. 2011.

15. Kraemer DL, Awad IA. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia 35 Suppl. 6:S30–S43. 1994.

16. Menzler K, Chen X, Thiel P, Iwinska-Zelder J, Miller D, Reuss A, et al. Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery. 67:918–924. 2010.

17. Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM. Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry. 66:561–568. 1999.

18. Noto S, Fujii M, Akimura T, Imoto H, Nomura S, Kajiwara K, et al. Management of patients with cavernous angiomas presenting epileptic seizures. Surg Neurol. 64:495–498. discussion 498-499. 2005.

19. Raabe A, Schmitz AK, Pernhorst K, Grote A, von der Brelie C, Urbach H, et al. Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions. Epilepsia. 53:539–548. 2012.

20. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 75:709–714. 1991.

21. Rosenow F, Alonso-Vanegas MA, Baumgartner C, Blümcke I, Carreño M, Gizewski ER, et al. Cavernoma-related epilepsy: review and recommendations for management--report of the surgical task force of the ILAE commission on therapeutic strategies. Epilepsia. 54:2025–2035. 2013.

22. Sanmillan JL, Lopez-Ojeda P, Fernández-Conejero I, Fernández-Coello A, Plans G, Ali-Ciurana Y, et al. Treatment of cavernous malformations in supratentorial eloquent areas: experience after 10 years of patient-tailored surgical protocol. Acta Neurochir (Wien). 160:1963–1974. 2018.

23. Sevy A, Gavaret M, Trebuchon A, Vaugier L, Wendling F, Carron R, et al. Beyond the lesion: the epileptogenic networks around cavernous angiomas. Epilepsy Res. 108:701–708. 2014.

24. Siegel AM, Roberts DW, Harbaugh RE, Williamson PD. Pure lesionectomy versus tailored epilepsy surgery in treatment of cavernous malformations presenting with epilepsy. Neurosurg Rev. 23:80–83. 2000.

25. Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery. 63:888–896. discussion 897. 2008.

26. Van Gompel JJ, Rubio J, Cascino GD, Worrell GA, Meyer FB. Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach? J Neurosurg. 110:1179–1185. 2009.

27. von der Brelie C, Malter MP, Niehusmann P, Elger CE, von Lehe M, Schramm J. Surgical management and long-term seizure outcome after epilepsy surgery for different types of epilepsy associated with cerebral cavernous malformations. Epilepsia. 54:1699–1706. 2013.

28. von der Brelie C, Schramm J. Cerebral cavernous malformations and intractable epilepsy: the limited usefulness of current literature. Acta Neurochir (Wien). 153:249–259. 2011.

29. Yang PF, Pei JS, Jia YZ, Lin Q, Xiao H, Zhang TT, et al. Surgical management and long-term seizure outcome after surgery for temporal lobe epilepsy associated with cerebral cavernous malformations. World Neurosurg. 110:e659–e670. 2018.

30. Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC. Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure. 18:14–20. 2009.

31. Zanello M, Meyer B, Still M, Goodden JR, Colle H, Schichor C, et al. Surgical resection of cavernous angioma located within eloquent brain areas: International survey of the practical management among 19 specialized centers. Seizure. 69:31–40. 2019.